Additional information
by Conrad Fischer (Author)
High-yield USMLE Step 2 CK review using the Fischer Method! Using proven strategies from USMLE expert Dr. Conrad Fischer, Master the Boards USMLE Step 2 CK has the targeted review you need to excel on the exam and match into the residency program you want.
- Exam-like focus using the Fischer Method: most likely diagnosis, best initial test, most accurate test, and best initial treatment
- Step-by-step approach to patient care
- Flow charts, decision trees, and comparison tables condense broad topics at a glance
- Hundreds of full-color diagnostic images
- Expert tips for recognizing incorrect answers
- Disciplines reordered alphabetically by chapter name for ease of reference.
- Current guidelines incorporated globally to reflect current standards of care.
- High-yield sidebars added throughout the book, including highly tested new medications.
- New discussions, including: neonatal intraventricular hemorrhage, persistent pulmonary hypertension, and protein intolerance; renal cell cancer, chemo-induced nausea, macular degeneration, emphysematous cholecystitis, postcholecystectomy syndrome, porcelain gallbladder, bile acid diarrhea, penile fracture
- Multiple sections reorganized and distilled, including: DM, lung cancer comorbidities, MS, myelomas, sodium disorders, parkinsonism, rheumatoid arthritis, pneumonia vax recommendations, and stroke protocols
Publisher's Note: Products purchased from 3rd party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entities included with the product.
Author Biography
Conrad Fischer, MD (Brooklyn, NY), is program director of the Internal Medicine residency program at Brookdale University Hospital and Medical Center, as well as professor of medicine at Touro College of Osteopathic Medicine in New York City. He teaches USMLE Steps 1, 2, and 3; Internal Medicine Board Review and Attending Recertification; and USMLE Step 1 Physiology.
Number of Pages: 736
Dimensions: 1 x 10.8 x 8.3 IN
Publication Date: November 04, 2025
